147 related articles for article (PubMed ID: 30522174)
21. Sinonasal tract and nasopharyngeal melanomas: a clinicopathologic study of 115 cases with a proposed staging system.
Thompson LD; Wieneke JA; Miettinen M
Am J Surg Pathol; 2003 May; 27(5):594-611. PubMed ID: 12717245
[TBL] [Abstract][Full Text] [Related]
22. Impact of adjuvant therapy on survival for sinonasal mucosal melanoma.
Lai Y; Meng X; Liu Q; Lu H; Guo L; Wang S; Wang D
Acta Otolaryngol; 2020 Jan; 140(1):79-84. PubMed ID: 31755795
[No Abstract] [Full Text] [Related]
23. Comparison of MITF and Melan-A Immunohistochemistry During Mohs Surgery for Lentigo Maligna-Type Melanoma In Situ and Lentigo Maligna Melanoma.
Christensen KN; Hochwalt PC; Hocker TL; Roenigk RK; Brewer JD; Baum CL; Otley CC; Arpey CJ
Dermatol Surg; 2016 Feb; 42(2):167-75. PubMed ID: 26771682
[TBL] [Abstract][Full Text] [Related]
24. MITF positivity in atypical fibroxanthoma: a diagnostic pitfall.
Tallon B; Beer TW
Am J Dermatopathol; 2014 Nov; 36(11):888-91. PubMed ID: 25238448
[TBL] [Abstract][Full Text] [Related]
25. Expression of p16 in sinonasal malignant melanoma.
Franchi A; Alos L; Gale N; Massi D; Paglierani M; Santucci M; Zidar N; Cardesa A
Virchows Arch; 2006 Dec; 449(6):667-72. PubMed ID: 17091256
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical analysis of Bcl-2, nuclear S100A4, MITF and Ki67 for risk stratification of early-stage melanoma - A combined IHC score for melanoma risk stratification.
Jurmeister P; Bockmayr M; Treese C; Stein U; Lenze D; Jöhrens K; Friedling F; Dietel M; Klauschen F; Marsch W; Fiedler E; von Laffert M
J Dtsch Dermatol Ges; 2019 Aug; 17(8):800-808. PubMed ID: 31437373
[TBL] [Abstract][Full Text] [Related]
27. Treatment modalities in sinonasal mucosal melanoma: A national cancer database analysis.
Ganti A; Raman A; Shay A; Kuhar HN; Auger SR; Patel T; Kuan EC; Diaz AZ; Batra PS; Tajudeen BA
Laryngoscope; 2020 Feb; 130(2):275-282. PubMed ID: 31021415
[TBL] [Abstract][Full Text] [Related]
28. [Sinonasal mucosal melanoma].
Pomar Blanco P; San Román Carbajo J; Bouso Montero M; Martín Villares C; Fernández Pello M; Tapia Risueño M
An Otorrinolaringol Ibero Am; 2007; 34(4):349-58. PubMed ID: 17844954
[TBL] [Abstract][Full Text] [Related]
29. Definitive Carbon-Ion Radiation Therapy for Locally Advanced Sinonasal Malignant Tumors: Subgroup Analysis of a Multicenter Study by the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS).
Koto M; Demizu Y; Saitoh JI; Suefuji H; Tsuji H; Okimoto T; Ohno T; Shioyama Y; Ikawa H; Nemoto K; Nakano T; Kamada T;
Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):353-361. PubMed ID: 30191869
[TBL] [Abstract][Full Text] [Related]
30. Microphthalmia transcription factor analysis in posterior uveal melanomas.
Mouriaux F; Vincent S; Kherrouche Z; Maurage CA; Planque N; Monté D; Labalette P; Saule S
Exp Eye Res; 2003 Jun; 76(6):653-61. PubMed ID: 12742347
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical profile of oral mucosal and head and neck cutaneous melanoma.
Alaeddini M; Etemad-Moghadam S
J Oral Pathol Med; 2015 Mar; 44(3):234-8. PubMed ID: 25048051
[TBL] [Abstract][Full Text] [Related]
32. High prevalence of MiTF staining in undifferentiated pleomorphic sarcoma: caution in the use of melanocytic markers in sarcoma.
Choy B; Hyjek E; Montag AG; Pytel P; Haydon R; Luu HH; Zhen CJ; Long BC; Kadri S; Segal JP; Furtado LV; Cipriani NA
Histopathology; 2017 Apr; 70(5):734-745. PubMed ID: 27926791
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical analysis of molecular drivers in melanoma identifies p16 as an independent prognostic biomarker.
Lade-Keller J; Riber-Hansen R; Guldberg P; Schmidt H; Hamilton-Dutoit SJ; Steiniche T
J Clin Pathol; 2014 Jun; 67(6):520-8. PubMed ID: 24607493
[TBL] [Abstract][Full Text] [Related]
34. Sinonasal malignant melanoma. A clinicopathologic and immunohistochemical study of 14 cases.
Franquemont DW; Mills SE
Am J Clin Pathol; 1991 Dec; 96(6):689-97. PubMed ID: 1720920
[TBL] [Abstract][Full Text] [Related]
35. Microphthalmia transcription factor as a molecular marker for circulating tumor cell detection in blood of melanoma patients.
Koyanagi K; O'Day SJ; Gonzalez R; Lewis K; Robinson WA; Amatruda TT; Kuo C; Wang HJ; Milford R; Morton DL; Hoon DS
Clin Cancer Res; 2006 Feb; 12(4):1137-43. PubMed ID: 16489066
[TBL] [Abstract][Full Text] [Related]
36. Primary mucosal melanomas of the nasal cavity and paranasal sinuses. A clinicopathological analysis of 14 cases.
Regauer S; Anderhuber W; Richtig E; Schachenreiter J; Ott A; Beham A
APMIS; 1998 Mar; 106(3):403-10. PubMed ID: 9548430
[TBL] [Abstract][Full Text] [Related]
37. Soft tissue tumors of the sinonasal tract.
Johncilla M; Jo VY
Semin Diagn Pathol; 2016 Mar; 33(2):81-90. PubMed ID: 26472693
[TBL] [Abstract][Full Text] [Related]
38. Primary mucosal melanoma of the head and neck. Comparison of clinical presentation and histopathologic features of oral and sinonasal melanoma.
McLean N; Tighiouart M; Muller S
Oral Oncol; 2008 Nov; 44(11):1039-46. PubMed ID: 18396446
[TBL] [Abstract][Full Text] [Related]
39. Expression of survivin, CD117, and C-erbB-2 in neuroendocrine carcinoma of the uterine cervix.
Sukpan K; Settakorn J; Khunamornpong S; Cheewakriangkrai C; Srisomboon J; Siriaunkgul S
Int J Gynecol Cancer; 2011 Jul; 21(5):911-7. PubMed ID: 21633298
[TBL] [Abstract][Full Text] [Related]
40. Sinonasal neuroendocrine carcinoma exhibiting amphicrine differentiation.
McCluggage WG; Napier SS; Primrose WJ; Adair RA; Toner PG
Histopathology; 1995 Jul; 27(1):79-82. PubMed ID: 7557912
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
